piracetam has been researched along with Common Migraine in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We assessed the effects of a 2-month treatment with topiramate or levetiracetam vs placebo on contingent negative variation (CNV) habituation and amplitude in a cohort of migraine without aura (MO) patients." | 5.13 | Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. ( De Stefano, G; de Tommaso, M; Di Claudio, T; Guido, M; Livrea, P; Sardaro, M; Serpino, C; Specchio, LM; Vecchio, E, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Tommaso, M | 1 |
| Guido, M | 1 |
| Sardaro, M | 1 |
| Serpino, C | 1 |
| Vecchio, E | 1 |
| De Stefano, G | 1 |
| Di Claudio, T | 1 |
| Specchio, LM | 1 |
| Livrea, P | 1 |
1 trial available for piracetam and Common Migraine
| Article | Year |
|---|---|
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients.
Topics: Acoustic Stimulation; Adolescent; Adult; Analysis of Variance; Anticonvulsants; Contingent Negative | 2008 |